Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6253237 | 7038918 | F | 6253237-3 | 20090626 | 20090701 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-14619126 | BRISTOL-MYERS SQUIBB COMPANY | 27 | YR | M | Y | 20090701 | MD | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6253237 | 1011824832 | PS | ABILIFY | 1 | INTRAMUSCULAR | ||||||
| 6253237 | 1011824833 | SS | TERCIAN | 2 | |||||||
| 6253237 | 1011824834 | C | FLUANXOL | 2 | FLUANXOL LP | ||||||
| 6253237 | 1011824835 | C | LOXAPAC | 2 | |||||||
| 6253237 | 1011824836 | C | DEPAMIDE | 2 | |||||||
| 6253237 | 1011824837 | C | LORAZEPAM | 1 | |||||||
| 6253237 | 1011824838 | C | TEMESTA | 2 | ORAL | FORM TAB | |||||
| 6253237 | 1011824839 | C | PARKINANE | 2 | ORAL | PARKINANE LP 1 DF = 1 CAPS 5 MG |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6253237 | 1011824832 | SCHIZOPHRENIA, PARANOID TYPE |
| 6253237 | 1011824833 | AGITATION |
| 6253237 | 1011824838 | ANXIETY |
| 6253237 | 1011824839 | EXTRAPYRAMIDAL DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6253237 | LT |
| 6253237 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6253237 | HYPOTENSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6253237 | 1011824832 | 20090430 | |||
| 6253237 | 1011824833 | 20090430 | |||
| 6253237 | 1011824838 | 20090430 | |||
| 6253237 | 1011824839 | 20090430 |